-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes Autolus Therapeutics at Buy, Announces Price Target of $10

Benzinga·11/02/2026 11:52:01
Diffusion vocale
HC Wainwright & Co. analyst Douglas Tsao assumes Autolus Therapeutics (NASDAQ:AUTL) with a Buy rating and announces Price Target of $10.